India's Snakebite Crisis: Healthcare Challenges

India faces a severe public health crisis with approximately 50,000 snakebite deaths annually, accounting for half of global fatalities. A report by the Global Snakebite Task Force (GST) reveals that 99% of healthcare workers in India, Brazil, Indonesia, and Nigeria struggle with antivenom administration due to poor infrastructure, limited supply, and insufficient training. The International===World Health Organization (WHO) classified snakebite envenoming as a 'highest priority neglected tropical disease' in 2017. In India, rural communities, particularly farmers and tribal groups, are most vulnerable, facing delays in hospital care due to bad roads and lack of ambulances. Dr. Yogesh Jain, a GST member, highlights that snakebites are often overlooked as a 'poor person's problem.' The National Action Plan for Prevention and Control of Snakebite Envenoming (NAPSE) was launched in 2024 to halve deaths by 2030, focusing on surveillance, antivenom availability, medical capacity, and public awareness, but implementation is inconsistent. Gerry Martin of The Liana Trust points out the lack of targeted antivenom for many snake species beyond the 'big four,' and the India===All India Institute of Medical Sciences, Jodhpur study confirmed the need for region-specific antivenom.